ApoGen Biotechnologies, Inc.
Biotechnology company · Seattle, Washington, United States
ApoGen Biotechnologies, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $7.6 million sold in a notice filed in 2018.
ApoGen Biotechnologies at a glance
What does ApoGen Biotechnologies do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $7.6 million sold (2018).
Frequently asked questions about ApoGen Biotechnologies
Where is ApoGen Biotechnologies headquartered?
ApoGen Biotechnologies, Inc. is headquartered in Seattle, Washington, United States.
What does ApoGen Biotechnologies do?
ApoGen Biotechnologies, Inc. is a biotechnology company.
When was ApoGen Biotechnologies founded?
The earliest incorporation on record for ApoGen Biotechnologies, Inc. is in 2014, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences